Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RI-002 in Primary Immunodeficiency Diseases
NCT01814800Phase 3Completed
- Sponsor
- ADMA Biologics, Inc.
- Start
- Feb 2014
- Primary completion
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of immune globulin intravenous, human-slra in primary immunodeficiency disease (PID), sponsored by ADMA Biologics, Inc.. Started Feb 2014; status: completed.
02
Drugs
immune globulin intravenous, human-slra
03
Conditions
primary immunodeficiency disease (PID)
Beyond the preview
Go deeper on NCT01814800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01814800.